β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99,0% (HPLC) Clofarabine Intermediate High Purity Featured Image

β-D-Ribofuranose 1-Asetat 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99,0% (HPLC) Clofarabine Intermediate High Purity

Katrangan singkat:

Nama: β-D-Ribofuranose 1-Asetat 2,3,5-Tribenzoate

CAS: 6974-32-9

Penampilan: Bubuk Kristal Putih utawa Off-White

Assay: ≥99,0% (HPLC)

Intermediate of Clofarabine (CAS: 123318-82-1) ing perawatan Anak karo Leukemia Limfoblastik Akut (ALL)

Inquiry: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Pasokan Komersial Clofarabine Related Intermediates:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Asetat 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Sifat Kimia:

Jeneng Kimia	β-D-Ribofuranose 1-Asetat 2,3,5-Tribenzoate
sinonim	1-O-Asetil-2,3,5-tri-O-benzoil-β-D-Ribofuranose
Nomer CAS	6974-32-9
Nomer CAT	RF-PI222
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C28H24O9
Bobot Molekul	504.49
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk Kristal Putih utawa Off-White
Metode Assay/Analisis	≥99,0% (HPLC)
Titik Lebur	126,0 ~ 133,0 ℃
Mundhut ing Pangatusan	≤0,50%
Sisa ing Ignition	≤0,50%
Total Impurities	≤1,00%
Logam abot	≤20ppm
Standar Tes	Standar Perusahaan
Panggunaan	Pharmaceutical Intermediate saka Clofarabine CAS: 123318-82-1

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.

Kaluwihan:

FAQ:

Aplikasi:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) minangka perantara saka (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) minangka obat antikanker nukleosida purin sing pisanan dikembangake dening perusahaan biopharmaceutical Top10 saka United States-Genzyme Corporation kanthi jeneng dagang "Clofarabine".Ing tanggal 28 Desember 2004, US Food and Drug Administration (FDA) nggunakake jalur cepet kanggo persetujuan clofarabine kanggo aplikasi kanggo bocah-bocah kanthi leukemia limfositik akut refrakter utawa kambuh (ALL);nduweni khasiat banget kanggo perawatan leukemia kanthi toleransi sing apik lan ora ana reaksi salabetipun sing ora bisa ditebak.Bisa ditindakake kanthi intravena utawa sacara lisan.Obat iki minangka produk pisanan sing disetujoni kanggo perawatan leukemia bocah-bocah ing luwih saka sepuluh taun.